Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Grazia Caivano"'
Autor:
Carsten Schwarz, Claudio Procaccianti, Laura Costa, Riccardo Brini, Richard Friend, Grazia Caivano, Hosein Sadafi, Charles Mussche, Nicolas Schwenck, Michael Hahn, Xabier Murgia, Federico Bianco
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 17; Pages: 9597
We compared the performance and levofloxacin (Quinsair) lung deposition of three nebulisers commonly used in CF (I-Neb Advance, eFlow rapid, and LC Plus) with the approved nebuliser Zirela. The delivered dose, delivery rate, and aerosol particle size
Autor:
Pierre Lambert, Fabio Sonvico, Rene Bommer, Grazia Caivano, Marie Hellfritzsch, Wilbur de Kruijf, Francesca Schiaretti, Gerallt Williams, Marie Trenkel, Alain Regard, Laurent Vecellio, Regina Scherließ, Jonathan Goole, Ben Forbes
Publikováno v:
Expert opinion on drug delivery
Expert Opinion on Drug Delivery
Expert Opinion on Drug Delivery, Taylor & Francis, 2020, 17 (2), pp.127-132. ⟨10.1080/17425247.2020.1714589⟩
Expert Opinion on Drug Delivery, 2020, 17 (2), pp.127-132. ⟨10.1080/17425247.2020.1714589⟩
Expert Opinion on Drug Delivery
Expert Opinion on Drug Delivery, Taylor & Francis, 2020, 17 (2), pp.127-132. ⟨10.1080/17425247.2020.1714589⟩
Expert Opinion on Drug Delivery, 2020, 17 (2), pp.127-132. ⟨10.1080/17425247.2020.1714589⟩
Nasal drug delivery has specific challenges which are distinct from oral inhalation, alongside which it is often considered. The next generation of nasal products will be required to deliver new classes of molecule, e.g. vaccines, biologics and drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64181aedabda8e2ca2bf9e5e73136e1
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/300963
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/300963
Autor:
Peter Field, Fiona O’Brien, David E. Clapham, Hannah Batchelor, Anthony J Nunn, Marisa Pertile, Catherine Tuleu, Grazia Caivano, Kamelia Krysiak
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 11, p 2688 (2019)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
International Journal of Molecular Sciences
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
International Journal of Molecular Sciences
The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However,
Autor:
Valeria Cavatorta, Serena Faggiano, Samanta Raboni, Luca Ronda, Elisa Sgarbi, Franco Sartor, Andrea Mozzarelli, Grazia Caivano, Marisa Pertile
Publikováno v:
International journal of pharmaceutics
553 (2018): 290–297. doi:10.1016/j.ijpharm.2018.10.045
info:cnr-pdr/source/autori:Faggiano S, Ronda L, Raboni S, Sartor F, Cavatorta V, Sgarbi E, Caivano G, Pertile M, Mozzarelli A/titolo:Phospholipid components of the synthetic pulmonary surfactant CHF5633 probed by fluorescence spectroscopy/doi:10.1016%2Fj.ijpharm.2018.10.045/rivista:International journal of pharmaceutics (Print)/anno:2018/pagina_da:290/pagina_a:297/intervallo_pagine:290–297/volume:553
553 (2018): 290–297. doi:10.1016/j.ijpharm.2018.10.045
info:cnr-pdr/source/autori:Faggiano S, Ronda L, Raboni S, Sartor F, Cavatorta V, Sgarbi E, Caivano G, Pertile M, Mozzarelli A/titolo:Phospholipid components of the synthetic pulmonary surfactant CHF5633 probed by fluorescence spectroscopy/doi:10.1016%2Fj.ijpharm.2018.10.045/rivista:International journal of pharmaceutics (Print)/anno:2018/pagina_da:290/pagina_a:297/intervallo_pagine:290–297/volume:553
CHF5633 (Chiesi Farmaceutici, Italy) is a synthetic pulmonary surfactant currently under clinical development for the treatment of Respiratory Distress Syndrome in premature infants. The product is composed of phospholipids in liposomal organization,
Autor:
Stefania Beato, Zadeo Cimarosti, Andrea Casazza, Stefano Provera, Carla Marchioro, Grazia Caivano, Lucilla Turco
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 54(1)
The aggregation behaviour of casopitant mesylate, a new NK1 antagonist drug, was investigated by means of NMR spectroscopy and surface tension measurements. The critical micelle concentration (CMC) in glycine buffer at pH 3.5 was determined by analyz